ALK-positive Non-small Cell Lung Cancer

Explore clinical trials studying ALK-positive Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

5 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

ALK-positive Non-small Cell Lung Cancer trial results

Recruiting

NCT07491497

Conditions: ALK-Positive Lung Cancer, ALK-positive NSCLC, ALK-positive Non-small Cell Lung Cancer
Locations: UCSF San Francisco, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Center Boston, Massachusetts, United States

Recruiting

NCT04900935

Conditions: ALK-positive Non-small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +14 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Recruiting

NCT06361589

Enrolling by Invitation

NCT06846736

Completed

NCT02336451

Conditions: ALK-positive Non-small Cell Lung Cancer, Brain Diseases, Brain Neoplasms, +14 more
Locations: USC Kenneth Norris Comprehensive Cancer Center SC-3 Los Angeles, California, United States

Stanford Universtiy Medical Center SC-5 Stanford, California, United States

Memorial Hospital of South Bend South Bend, Indiana, United States

Dana Farber Cancer Institute SC-12 Boston, Massachusetts, United States

View all 57 locations